Cost analysis of debridement and retention for management of prosthetic joint infection

Clinical Microbiology and Infection

Volumn 19, Issue 2, 2013, Pages 181-186

  Peel, T N ^a,b   Dowsey, M M ^a,b   Buising, K L ^a   Liew, D ^b,c   Choong, P F M ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Biostatistics and Health Services Research   (Australia)

Author keywords

Case control study; Debridement and retention; Economic analysis; Prosthetic joint infection

Indexed keywords

AGED; ARTHROPLASTY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEBRIDEMENT; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; JOINT PROSTHESIS; LENGTH OF STAY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTHESIS INFECTION; TREATMENT FAILURE;

EID: 84873522655     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03758.x     Document Type: Article

References (20)

1. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-1654.
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg 2007; 89(A): 780-785.
3. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005; 87: 1746-1751.
4. Dowsey MM, Liew D, Stoney JD, Choong PF. The impact of pre-operative obesity on weight change and outcome in total knee replacement: a prospective study of 529 consecutive patients. J Bone Joint Surg Br 2010; 92: 513-520.
5. Aboltins CA, Dowsey MM, Buising KL et al. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbiol Infect 2011; 17: 862-867.
6. Choong PFM, Dowsey MM, Carr D, Daffy J, Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthop 2007; 78: 755-765.
7. Aboltins CA, Page MA, Buising KL, Jenney AWJ, Daffy JR, Choong PFM. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007; 13: 586-591.
8. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori GT. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13: 606-608.
9. US National Library of Medicine. Medical Subject Heading (MeSH) - episode of care. Bethesda: National Institutes of Health, 2011. Available at: http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi (last accessed 21 July 2011).
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
11. Australian Bureau of Statistics. SEIFA: socio-economic indexes for areas. ABS, 2008. Available at: http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Seifa_entry_page (last accessed 21 July 2011).
12. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopaedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay and extra cost. Infect Control Hosp Epidemiol 2002; 23: 183-189.
13. Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop Relat Res 1996; 331: 140-145.
14. Sculco TP. The economic impact of infected total joint arthroplasty. Instr Course Lect 1993; 42: 349-351.
15. Barrack RL, Sawhney J, Hsu J, Cofield RH. Cost analysis of revision total hip arthroplasty. Clin Orthop Relat Res 1999; 369: 175-178.
16. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res 2010; 96: 124-132.
17. Hellmann M, Mehta SD, Bishai DM, Mears SC, Zenilman JM. The estimated magnitude and direct hospital costs of prosthetic joint infections in the United States, 1997 to 2004. J Arthroplasty 2010; 25: 766-71.e1.
18. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-919.
19. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 2008; 10: 394-403.
20. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419-430.